Primers on molecular pathways - cycling toward pancreatic cancer.
Liu
Yang
Y
Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minn., USA.
Elsawa
Sherine F
SF
Almada
Luciana L
LL
D000230:Adenocarcinoma / Q000235:genetics; D000328:Adult; D002453:Cell Cycle / Q000502:physiology*; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000502:physiology; D016213:Cyclins / Q000378:metabolism; D004249:DNA Damage / Q000502:physiology; D044127:Epigenesis, Genetic; D006801:Humans; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000503:physiopathology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D016213:Cyclins; D016159:Tumor Suppressor Protein p53; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases